These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 3138024)
1. Differential regulation of plasminogen activators by epidermal growth factor in normal and neoplastic human urothelium. Dubeau L; Jones PA; Rideout WM; Laug WE Cancer Res; 1988 Oct; 48(19):5552-6. PubMed ID: 3138024 [TBL] [Abstract][Full Text] [Related]
2. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. Piedagnel R; Tiger Y; Lelongt B; Ronco PM J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905 [TBL] [Abstract][Full Text] [Related]
3. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Messing EM Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599 [TBL] [Abstract][Full Text] [Related]
4. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts. Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010 [TBL] [Abstract][Full Text] [Related]
6. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. De Petro G; Copeta A; Barlati S Exp Cell Res; 1994 Jul; 213(1):286-94. PubMed ID: 8020601 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells. Silvy M; Giusti C; Martin PM; Berthois Y Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474 [TBL] [Abstract][Full Text] [Related]
8. Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-I and epidermal growth factor. Tranque P; Naftolin F; Robbins R Endocrinology; 1994 Jun; 134(6):2606-13. PubMed ID: 8194486 [TBL] [Abstract][Full Text] [Related]
9. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771 [TBL] [Abstract][Full Text] [Related]
10. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells. Kasza A; Kowanetz M; Poślednik K; Witek B; Kordula T; Koj A Cytokine; 2001 Dec; 16(5):187-90. PubMed ID: 11814314 [TBL] [Abstract][Full Text] [Related]
12. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro. Paciucci R; Torà M; Díaz VM; Real FX Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108 [TBL] [Abstract][Full Text] [Related]
13. Ethanol transcriptionally upregulates t-PA and u-PA gene expression in cultured human endothelial cells. Grenett HE; Aikens ML; Torres JA; Demissie S; Tabengwa EM; Davis GC; Booyse FM Alcohol Clin Exp Res; 1998 Jun; 22(4):849-53. PubMed ID: 9660311 [TBL] [Abstract][Full Text] [Related]
14. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells. Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589 [TBL] [Abstract][Full Text] [Related]
15. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice. de Vries TJ; Kitson JL; Silvers WK; Mintz B Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649 [TBL] [Abstract][Full Text] [Related]
16. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel. Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431 [TBL] [Abstract][Full Text] [Related]
17. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828 [TBL] [Abstract][Full Text] [Related]
18. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder. Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521 [TBL] [Abstract][Full Text] [Related]
19. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder. Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]